Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPM8 | Q7Z2W7 | 12/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
| ▸ | RAB9A | P51151 | 4/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.48 |
| ▸ | NPC1 | O15118 | 2/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | PPARG | P37231 | 1/20 | 0.46 |
| ▸ | PPARA | Q07869 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28194650 | 0.76 | HPGD (0.59) | TRPM8TP53THRBHPGDRAB9A | |
| SCHEMBL27276885 | 0.76 | TRPM8 (0.51) | TRPM8TP53THRBHPGDRAB9A | |
| SCHEMBL9814972 | 0.75 | TRPM8 (0.50) | TRPM8TP53THRBHPGDRAB9A | |
| SCHEMBL28254369 | 0.74 | HPGD (0.57) | TRPM8TP53THRBHPGDRAB9A | |
| SCHEMBL5758339 | 0.72 | RAB9A (0.58) | HPGDRAB9ACYP2C19NPC1 | |
| SCHEMBL28195169 | 0.72 | HPGD (0.62) | TRPM8TP53THRBHPGDRAB9A | |
| SCHEMBL28254374 | 0.72 | HPGD (0.55) | TRPM8TP53THRBHPGDRAB9A | |
| SCHEMBL6122797 | 0.72 | CYP2C19 (0.61) | HPGDRAB9ACYP2C19NPC1 | |
| SCHEMBL1905227 | 0.71 | CYP2C19 (0.59) | HPGDRAB9ACYP2C19NPC1 | |
| SCHEMBL2712722 | 0.71 | CYP2C19 (0.59) | RAB9ACYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11160894-B2 | Perfume emanating device | FIRMENICH SA (CH) | 2021-11-02 | — | — | US | disclosed |
| US-20180264156-A1 | PERFUME EMANATING DEVICE | FIRMENICH SA (CH) | 2018-09-20 | — | — | US | disclosed |
| EP-3355944-A1 | PERFUME EMANATING DEVICE | Firmenich SA (CH) | 2018-08-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11160894-B2 | Perfume emanating device | DPM1, SURF4, FAAH2 | TRPM8 151/4885TP53 3063/4885THRB 4444/4885 |
| US-20180264156-A1 | PERFUME EMANATING DEVICE | DPM1, SURF4, FAAH2 | TRPM8 151/4885TP53 3063/4885THRB 4444/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.